Gschwantler, Michael
Bamberger, Thomas
Graziadei, Ivo
Maieron, Andreas
Katalinic, Nives http://orcid.org/0000-0002-0484-8143
Stauber, Rudolf
Funding for this research was provided by:
AbbVie
Article History
Received: 18 July 2018
Accepted: 16 October 2018
First Online: 14 November 2018
Compliance with ethical guidelines
:
: AbbVie sponsored this study and contributed to the design, study conduct, and analysis. AbbVie participated in the interpretation of data, review, and approval of the manuscript. All authors had access to all relevant data. M. Gschwantler: advisor for AbbVie, Gilead, BMS, MSD, and Janssen; received speaker fees from AbbVie, Gilead, BMS, MSD, and Janssen; grants from AbbVie, Gilead and MSD. T. Bamberger: advisor for AbbVie, BMS, and MSD; received speaker fees from AbbVie, Gilead, and BMS. I. Graziadei: advisory board: AbbVie, Gilead, BMS, MSD, and Janssen; received speaker fees from AbbVie, Gilead, BMS, and MSD. A. Maieron: advisor for AbbVie, Gilead, BMS, MSD, and Janssen; received speaker fees from AbbVie, Gilead, BMS, MSD, and Janssen. N. Katalinic: AbbVie employee and may hold AbbVie stock or options. R. Stauber: advisor for AbbVie, BMS, Gilead, and MSD; received speaker fees from AbbVie, BMS, and Gilead; and research grant from AbbVie.
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all patients included in the study.